The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis.


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
09 2019
Historique:
received: 01 08 2019
accepted: 02 09 2019
entrez: 3 10 2019
pubmed: 3 10 2019
medline: 3 3 2020
Statut: ppublish

Résumé

The aim of this systematic review and meta-analysis was to evaluate the benefit of platelet rich plasma (PRP) in oral surgery. We performed a systematic search of the literature. The GRADE system was used to assess the certainty of the body of evidence. We found 21 randomised controlled trials that met our inclusion criteria: 12 studies included patients with periodontal defects, five studies focused on healing of extraction sockets, three studies on sinus lift augmentation, and one study on periapical osseous defects. However, for the quantitative synthesis (meta-analysis), we evaluated "periodontal defects" studies only, since for other clinical contexts the number of studies were too low and the procedural heterogeneity was too high to allow pooling of data. PRP-containing regimens were compared to non-PRP-containing regimens. Primary outcomes for the evaluation of periodontal defects were probing depths, clinical attachment level, gingival recession, and radiographic bone defect. It is not usually clear whether or not the use of PRP compared to controls affects "probing depth" at long-term follow up; the between group differences were small and unlikely to be of clinical importance (i.e., very low quality of evidence). For the other outcomes analysed ("clinical attachment levels", "gingival recession", "bony defect"), we observed a very slight marginal clinical benefit of PRP compared to controls. The available evidence for these comparisons was rated as low quality as most of the studies selected showed inconsistency, imprecision, and risk of bias. Evidence from a comparison between the use in oral surgery of PRP-containing regimens compared to other regimens not-containing PRP was of low quality. The results of the meta-analysis, limited to studies in patients with periodontal defects, document that PRP was slightly more effective compared to controls not-containing PRP.

Sections du résumé

BACKGROUND
The aim of this systematic review and meta-analysis was to evaluate the benefit of platelet rich plasma (PRP) in oral surgery.
MATERIALS AND METHODS
We performed a systematic search of the literature. The GRADE system was used to assess the certainty of the body of evidence.
RESULTS
We found 21 randomised controlled trials that met our inclusion criteria: 12 studies included patients with periodontal defects, five studies focused on healing of extraction sockets, three studies on sinus lift augmentation, and one study on periapical osseous defects. However, for the quantitative synthesis (meta-analysis), we evaluated "periodontal defects" studies only, since for other clinical contexts the number of studies were too low and the procedural heterogeneity was too high to allow pooling of data. PRP-containing regimens were compared to non-PRP-containing regimens. Primary outcomes for the evaluation of periodontal defects were probing depths, clinical attachment level, gingival recession, and radiographic bone defect. It is not usually clear whether or not the use of PRP compared to controls affects "probing depth" at long-term follow up; the between group differences were small and unlikely to be of clinical importance (i.e., very low quality of evidence). For the other outcomes analysed ("clinical attachment levels", "gingival recession", "bony defect"), we observed a very slight marginal clinical benefit of PRP compared to controls. The available evidence for these comparisons was rated as low quality as most of the studies selected showed inconsistency, imprecision, and risk of bias.
DISCUSSION
Evidence from a comparison between the use in oral surgery of PRP-containing regimens compared to other regimens not-containing PRP was of low quality. The results of the meta-analysis, limited to studies in patients with periodontal defects, document that PRP was slightly more effective compared to controls not-containing PRP.

Identifiants

pubmed: 31577533
pii: 2019.0177-19
doi: 10.2450/2019.0177-19
pmc: PMC6774927
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-367

Références

Blood Transfus. 2018 Jul;16(4):329-337
pubmed: 29757132
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Periodontol. 2008 May;79(5):802-10
pubmed: 18454658
Vox Sang. 2008 Jan;94(1):64-9
pubmed: 18005082
Blood Transfus. 2018 Jan;16(1):36-43
pubmed: 29337665
Blood Transfus. 2018 May;16(3):235-243
pubmed: 29517967
J Clin Periodontol. 2009 Jul;36(7):581-8
pubmed: 19538331
Blood Transfus. 2017 Oct;15(6):506-511
pubmed: 27483483
Blood Transfus. 2018 Nov;16(6):471-472
pubmed: 30388070
Eur J Oral Implantol. 2010 Summer;3(2):121-34
pubmed: 20623037
J Maxillofac Oral Surg. 2015 Sep;14(3):808-15
pubmed: 26225080
J Periodontol. 2005 Jun;76(6):890-8
pubmed: 15948682
Blood Transfus. 2018 May;16(3):221-223
pubmed: 28488970
Blood Transfus. 2018 Nov;16(6):502-513
pubmed: 30201082
J Clin Periodontol. 2008 Mar;35(3):255-62
pubmed: 18190557
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):638-46
pubmed: 9638695
Biomed Res Int. 2018 May 27;2018:8670832
pubmed: 29977919
Blood Transfus. 2017 Jul;15(4):292-293
pubmed: 28488963
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
J Clin Periodontol. 2009 Aug;36(8):677-87
pubmed: 19563329
Blood Transfus. 2018 Jul;16(4):321-323
pubmed: 29757130
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
J Clin Periodontol. 2008 Jan;35(1):44-50
pubmed: 18034853
J Stomatol Oral Maxillofac Surg. 2019 Jun;120(3):196-202
pubmed: 30496845
Med Oral Patol Oral Cir Bucal. 2010 May 01;15(3):e483-9
pubmed: 20038911
Blood Transfus. 2016 Jan;14(1):1-2
pubmed: 26710350
Blood Transfus. 2018 May;16(3):224-226
pubmed: 29517964
J Oral Maxillofac Surg. 2017 Aug;75(8):1601-1615
pubmed: 28288724
J Periodontal Res. 2013 Oct;48(5):573-81
pubmed: 23317096
Curr Pharm Biotechnol. 2012 Jun;13(7):1231-56
pubmed: 21740370
Clin Oral Implants Res. 2018 Oct;29 Suppl 18:6-19
pubmed: 30306698
Blood Transfus. 2018 Jan;16(1):44-52
pubmed: 27723454
Blood Transfus. 2018 May;16(3):313-320
pubmed: 28488969
Blood Transfus. 2017 Jul;15(4):333-340
pubmed: 27483482
Blood Transfus. 2017 Sep;15(5):379-381
pubmed: 28880841
Blood Transfus. 2016 Jan;14(1):23-65
pubmed: 26710356
J Oral Maxillofac Surg. 2004 Apr;62(4):489-96
pubmed: 15085519
Am J Sports Med. 2009 Nov;37(11):2259-72
pubmed: 19875361
J Periodontol. 2011 May;82(5):660-7
pubmed: 21091351
Clin Oral Implants Res. 2003 Apr;14(2):213-8
pubmed: 12656882
Blood Transfus. 2018 Sep;16(5):438-442
pubmed: 30036177
Blood Transfus. 2018 Nov;16(6):490-497
pubmed: 30201083
Quintessence Int. 2012 Jul-Aug;43(7):571-82
pubmed: 22670252
J Oral Maxillofac Surg. 2011 Sep;69(9):2305-10
pubmed: 21550158
Int J Periodontics Restorative Dent. 2014 Sep-Oct;34(5):705-11
pubmed: 25171042
Cochrane Database Syst Rev. 2014 May 13;(5):CD008397
pubmed: 24825543
J Periodontol. 2014 May;85(5):661-8
pubmed: 23895252
Front Physiol. 2015 Oct 20;6:290
pubmed: 26539125
Blood Transfus. 2017 Sep;15(5):422-437
pubmed: 28880842
Int J Oral Maxillofac Implants. 2014 Mar-Apr;29(2):485-96
pubmed: 24683578
Blood Transfus. 2017 Oct;15(6):587-588
pubmed: 27893359
Clin Oral Investig. 2009 Jun;13(2):179-87
pubmed: 18766387
Blood Transfus. 2017 Jul;15(4):325-328
pubmed: 28488975
Indian J Dent Res. 2011 Jan-Feb;22(1):107-15
pubmed: 21525688
Blood Transfus. 2016 Mar;14(2):123-5
pubmed: 26950940
J Periodontol. 2009 Oct;80(10):1599-605
pubmed: 19792848
Blood Transfus. 2018 Jul;16(4):324-325
pubmed: 29517972
Curr Pharm Biotechnol. 2012 Jun;13(7):1207-30
pubmed: 21740371
J Investig Clin Dent. 2016 Feb;7(1):13-26
pubmed: 25048153
Blood Transfus. 2018 Jul;16(4):338-342
pubmed: 29517968

Auteurs

Massimo Franchini (M)

Italian National Blood Centre, National Institute of Health, Rome, Italy.
Department of Haematology and Transfusion Medicine, "Carlo Poma" Hospital, Mantua, Italy.

Mario Cruciani (M)

Italian National Blood Centre, National Institute of Health, Rome, Italy.
Infection Control Committee and Antibiotic Stewardship Programme, ULSS9 "Scaligera", Verona, Italy.

Carlo Mengoli (C)

Italian National Blood Centre, National Institute of Health, Rome, Italy.
Italian Foundation for Research on Anaemia and Haemoglobinopathies, Genoa, Italy.

Francesca Masiello (F)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Giuseppe Marano (G)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Ernesto D'Aloja (E)

Studio D'Aloja, Arbizzano di Negrar (VR), Italy.

Cristina Dell'Aringa (C)

Postgraduate School of Orthodontics, University of Ferrara, Ferrara, Italy.

Ilaria Pati (I)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Eva Veropalumbo (E)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Simonetta Pupella (S)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Stefania Vaglio (S)

Italian National Blood Centre, National Institute of Health, Rome, Italy.
Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Giancarlo M Liumbruno (GM)

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH